| |
Latest 10 SEC filings (by transaction date) for SRRK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 11/24 | Apr 9/24 | Peng Katie | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 35,767 | |
Apr 11/24 | Apr 9/24 | Peng Katie | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 26,825 | |
Feb 21/24 | Feb 16/24 | Myles Edward H | Direct Ownership | Common Stock | S - Open market or private sale | -4,744 | $15.74 |
Feb 20/24 | Feb 16/24 | Qatanani Mo | Direct Ownership | Common Stock | S - Open market or private sale | -2,512 | $15.74 |
Feb 20/24 | Feb 16/24 | Parlavecchio Caryn | Direct Ownership | Common Stock | S - Open market or private sale | -3,751 | $15.74 |
Feb 20/24 | Feb 16/24 | Ho Junlin | Direct Ownership | Common Stock | S - Open market or private sale | -3,489 | $15.74 |
Feb 20/24 | Feb 16/24 | Backstrom Jay T. | Direct Ownership | Common Stock | S - Open market or private sale | -11,614 | $15.74 |
Feb 13/24 | Feb 12/24 | Backstrom Jay T. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 285,715 | |
Feb 13/24 | Feb 12/24 | Backstrom Jay T. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 214,285 | |
Feb 13/24 | Feb 12/24 | Marantz Jing L. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 97,145 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for SRRK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 11/24 | Apr 9/24 | Peng Katie | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 35,767 | |
Apr 11/24 | Apr 9/24 | Peng Katie | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 26,825 | |
Feb 21/24 | Feb 16/24 | Myles Edward H | Direct Ownership | Common Stock | S - Open market or private sale | -4,744 | $15.74 |
Feb 20/24 | Feb 16/24 | Qatanani Mo | Direct Ownership | Common Stock | S - Open market or private sale | -2,512 | $15.74 |
Feb 20/24 | Feb 16/24 | Parlavecchio Caryn | Direct Ownership | Common Stock | S - Open market or private sale | -3,751 | $15.74 |
Feb 20/24 | Feb 16/24 | Ho Junlin | Direct Ownership | Common Stock | S - Open market or private sale | -3,489 | $15.74 |
Feb 20/24 | Feb 16/24 | Backstrom Jay T. | Direct Ownership | Common Stock | S - Open market or private sale | -11,614 | $15.74 |
Feb 13/24 | Feb 12/24 | Backstrom Jay T. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 285,715 | |
Feb 13/24 | Feb 12/24 | Backstrom Jay T. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 214,285 | |
Feb 13/24 | Feb 12/24 | Marantz Jing L. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 97,145 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |